ST elevation myocardial infarction pacemaker implantation: Difference between revisions

Acute Coronary Syndrome Main Page
	ST Elevation Myocardial Infarction Microchapters
Home
Patient Information
Overview
Pathophysiology
Pathophysiology of Vessel Occlusion
Pathophysiology of Reperfusion
Gross Pathology
Histopathology
Causes
Differentiating ST elevation myocardial infarction from other Diseases
Epidemiology and Demographics
Risk Factors
Triggers
Natural History and Complications
Risk Stratification and Prognosis
Pregnancy
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
EKG Examples
Chest X Ray
Cardiac MRI
Echocardiography
Coronary Angiography
Treatment
Pre-Hospital Care
Initial Care Oxygen Nitrates Analgesics Aspirin Beta Blockers Antithrombins The coronary care unit The step down unit STEMI and Out-of-Hospital Cardiac Arrest Pharmacologic Reperfusion Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) Fibrinolysis Reperfusion at a Non–PCI-Capable Hospital:Recommendations Mechanical Reperfusion The importance of reducing Door-to-Balloon times Primary PCI Adjunctive and Rescue PCI Rescue PCI Facilitated PCI Adjunctive PCI CABG Management of Patients Who Were Not Reperfused Assessing Success of Reperfusion Antithrombin Therapy Antithrombin therapy Unfractionated heparin Low Molecular Weight Heparinoid Therapy Direct Thrombin Inhibitor Therapy Factor Xa Inhibition DVT prophylaxis Long term anticoagulation Antiplatelet Agents Aspirin Thienopyridine Therapy Glycoprotein IIbIIIa Inhibition Other Initial Therapy Inhibition of the Renin-Angiotensin-Aldosterone System Magnesium Therapy Glucose Control Calcium Channel Blocker Therapy Lipid Management
Pre-Discharge Care
Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT
Post Hospitalization Plan of Care
Long-Term Medical Therapy and Secondary Prevention Overview Inhibition of the Renin-Angiotensin-Aldosterone System Cardiac Rehabilitation Pacemaker Implantation Long Term Anticoagulation Implantable Cardioverter Defibrillator ICD implantation within 40 days of myocardial infarction ICD within 90 days of revascularization
Case Studies
Case #1
Case #2
Case #3
Case #4
Case #5
ST elevation myocardial infarction pacemaker implantation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on ST elevation myocardial infarction pacemaker implantation
CDC on ST elevation myocardial infarction pacemaker implantation
ST elevation myocardial infarction pacemaker implantation in the news
Blogs on ST elevation myocardial infarction pacemaker implantation
Directions to Hospitals Treating ST elevation myocardial infarction
Risk calculators and risk factors for ST elevation myocardial infarction pacemaker implantation

← Older edit Newer edit →

VisualWikitext

Revision as of 15:55, 31 October 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT)^[1]

Class I
"1. Permanent ventricular pacing is indicated for persistent second-degree AV block in the His-Purkinje system with alternating bundle-branch block or third-degree AV block within or below the His-Purkinje system after ST-segment elevation myocardial infarction. (Level of Evidence: B) "
"2. Permanent ventricular pacing is indicated for transient advanced second- or third-degree infranodal AV block and associated bundle-branch block. If the site of block is uncertain, an electrophysiological study may be necessary. (Level of Evidence: B) "
"3. Permanent ventricular pacing is indicated for persistent and symptomatic second- or third-degree AV block. (Level of Evidence: C) "

Class III (No Benefit)
" 1. Permanent ventricular pacing is not indicated for transient AV block in the absence of intraventricular conduction defects. (Level of Evidence: B) "
" 2. Permanent ventricular pacing is not indicated for transient AV block in the presence of isolated left anterior fascicular block. (Level of Evidence: B) "
" 3. Permanent ventricular pacing is not indicated for new bundle-branch block or fascicular block in the absence of AV block. (Level of Evidence: B) "
" 4. Permanent ventricular pacing is not indicated for persistent asymptomatic first-degree AV block in the presence of bundle-branch or fascicular block. (Level of Evidence: B) "

Class IIa
"1. Permanent ventricular pacing may be considered for persistent second- or third-degree infranodal AV block at the AV node level, even in the absence of symptoms. (Level of Evidence: B) "

Sources

The ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities ^[1]

References

↑ ^1.0 ^1.1 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207

Template:WikiDoc Sources

[Epstein-1] 1.0 ^1.1 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207

[1]

@@ Line 4: / Line 4: @@
 ==Overview==
-==ACC / AHA Guidelines- Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT) <ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>==
+==2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT)<ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>==
 {|class="wikitable"
@@ Line 10: / Line 10: @@
 | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
 |-
-| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Permanent [[ventricular pacing]] is indicated for persistent [[second-degree AV block]] in the [[Bundle of His|His]]-[[Purkinje fibers|Purkinje]] system with alternating [[bundle-branch block]] or [[third-degree AV block]] within or below the [[Bundle of His|His]]-[[Purkinje fibers|Purkinje]] system after [[ST-segment elevation MI]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
+| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Permanent [[ventricular pacing]] is indicated for persistent [[second-degree AV block]] in the [[Bundle of His|His]]-[[Purkinje fibers|Purkinje]] system with alternating [[bundle-branch block]] or [[third-degree AV block]] within or below the [[Bundle of His|His]]-[[Purkinje fibers|Purkinje]] system after [[ST-segment elevation myocardial infarction]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
 |-
 | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' Permanent [[ventricular pacing]] is indicated for transient advanced [[second-degree AV block|second-]] or [[third-degree infranodal AV block]] and associated [[bundle-branch block]]. If the site of block is uncertain, an electrophysiological study may be necessary. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
@@ Line 19: / Line 19: @@
 {|class="wikitable"
 |-
-| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
+|colspan="1" style="text-align:center; background:LightCoral"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (No Benefit)
+|-
+|bgcolor="LightCoral"| <nowiki>"</nowiki> '''1.''' Permanent [[ventricular pacing]] is not indicated for transient [[AV block]] in the absence of intraventricular conduction defects. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
+|-
+|bgcolor="LightCoral"|<nowiki>"</nowiki> '''2.''' Permanent [[ventricular pacing]] is not indicated for transient [[AV block]] in the presence of isolated [[left anterior fascicular block]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
+|-
+|bgcolor="LightCoral"| <nowiki>"</nowiki> '''3.''' Permanent [[ventricular pacing]] is not indicated for new [[bundle-branch block]] or [[fascicular block]] in the absence of [[AV block]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
 |-
-|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Permanent [[ventricular pacing]] may be considered for persistent [[second-degree AV block|second-]] or [[third-degree infranodal AV block]] at the AV node level, even in the absence of symptoms. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
+|bgcolor="LightCoral"| <nowiki>"</nowiki> '''4.''' Permanent [[ventricular pacing]] is not indicated for persistent asymptomatic [[first-degree AV block]] in the presence  of [[bundle-branch block|bundle-branch]] or [[fascicular block]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
 |}
 {|class="wikitable"
 |-
-|colspan="1" style="text-align:center; background:LightCoral"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (No Benefit)
+| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
 |-
-|bgcolor="LightCoral"| <nowiki>"</nowiki> '''1.''' Permanent [[ventricular pacing]] is not indicated for transient [[AV block]] in the absence of intraventricular conduction defects. ''(Level of Evidence: B)'' <nowiki>"</nowiki>
+|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Permanent [[ventricular pacing]] may be considered for persistent [[second-degree AV block|second-]] or [[third-degree infranodal AV block]] at the AV node level, even in the absence of symptoms. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki>
-|-
-|bgcolor="LightCoral"|<nowiki>"</nowiki> '''2.''' Permanent [[ventricular pacing]] is not indicated for transient [[AV block]] in the presence of isolated [[left anterior fascicular block]]. ''(Level of Evidence: B)'' <nowiki>"</nowiki>
-|-
-|bgcolor="LightCoral"| <nowiki>"</nowiki> '''3.''' Permanent [[ventricular pacing]] is not indicated for new [[bundle-branch block]] or [[fascicular block]] in the absence of [[AV block]]. ''(Level of Evidence: B)'' <nowiki>"</nowiki>
-|-
-|bgcolor="LightCoral"| <nowiki>"</nowiki> '''4.''' Permanent [[ventricular pacing]] is not indicated for persistent asymptomatic [[first-degree AV block]] in the presence  of [[bundle-branch block|bundle-branch]] or [[fascicular block]]. ''(Level of Evidence: B)'' <nowiki>"</nowiki>
 |}

ST elevation myocardial infarction pacemaker implantation: Difference between revisions

Revision as of 15:55, 31 October 2012

Contents

Overview

2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT)^[1]

Sources

References

Navigation menu

ST elevation myocardial infarction pacemaker implantation: Difference between revisions

Revision as of 15:55, 31 October 2012

Overview

2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT)[1]

Sources

References

Navigation menu

Search

2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Permanent Pacing After the Acute Phase of Myocardial Infarction (DO NOT EDIT)^[1]